XTAESOFW
Market cap155mUSD
Dec 24, Last price
1,648.00ILS
1D
-0.12%
1Q
-2.77%
IPO
-38.71%
Name
Sofwave Medical Ltd
Chart & Performance
P/E
—
P/S
309.59
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
50m
+41.22%
Net income
-8m
L-57.61%
CFO
-6m
L-41.03%
Earnings
Jan 22, 2025
Profile
Sofwave Medical Ltd. develops an ultrasound technology for treating fine lines and wrinkles in Israel and internationally. It offers non-invasive skin treatment aesthetic medical devices to physicians. The company was incorporated in 2015 and is based in Yokne'am Illit, Israel.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | |
| Income | ||||||
Revenues | 50,315 41.22% | 35,630 63.15% | 21,839 408.95% | |||
Cost of revenue | 38,382 | 32,821 | 19,526 | |||
Unusual Expense (Income) | ||||||
NOPBT | 11,933 | 2,809 | 2,313 | |||
NOPBT Margin | 23.72% | 7.88% | 10.59% | |||
Operating Taxes | 16 | 321 | (321) | |||
Tax Rate | 0.13% | 11.43% | ||||
NOPAT | 11,917 | 2,488 | 2,634 | |||
Net income | (8,278) -57.61% | (19,528) 186.08% | (6,826) -41.59% | |||
Dividends | ||||||
Dividend yield | ||||||
Proceeds from repurchase of equity | 4 | 30 | 46,960 | |||
BB yield | 0.00% | -0.01% | -6.89% | |||
| Debt | ||||||
Debt current | 562 | 594 | 607 | |||
Long-term debt | 2,096 | 3,254 | 4,123 | |||
Deferred revenue | ||||||
Other long-term liabilities | 414 | |||||
Net debt | (21,764) | (28,157) | (41,479) | |||
| Cash flow | ||||||
Cash from operating activities | (6,306) | (10,694) | (2,097) | |||
CAPEX | (407) | (447) | (821) | |||
Cash from investing activities | 409 | (260) | (982) | |||
Cash from financing activities | (1,723) | (1,347) | 46,644 | |||
FCF | 12,261 | 1,805 | (219) | |||
| Balance | ||||||
Cash | 24,422 | 32,005 | 46,209 | |||
Long term investments | ||||||
Excess cash | 21,906 | 30,224 | 45,117 | |||
Stockholders' equity | (53,477) | (34,182) | 46,702 | |||
Invested Capital | 81,149 | 68,445 | 4,364 | |||
ROIC | 15.93% | 6.83% | 65.69% | |||
ROCE | 43.11% | 8.20% | 4.67% | |||
| EV | ||||||
Common stock shares outstanding | 34,158 | 34,071 | 23,500 | |||
Price | 13.72 66.91% | 8.22 -71.66% | 29.00 | |||
Market cap | 468,647 67.34% | 280,064 -58.90% | 681,490 | |||
EV | 446,883 | 251,907 | 640,011 | |||
EBITDA | 13,438 | 3,928 | 2,672 | |||
EV/EBITDA | 33.26 | 64.13 | 239.52 | |||
Interest | 144 | 1,116 | 549 | |||
Interest/NOPBT | 1.21% | 39.73% | 23.74% | |||